Objective:

To assess the associations between serum testosterone and cardiometabolic risk in Nigerian men with Type 2 diabetes mellitus (T2DM).

Approach:

Key Findings:

• Men with T2DM had significantly higher ASCVD 10-year scores than non-diabetic controls, independent of testosterone status.
• Hypogonadal T2DM men exhibited higher BMI, central obesity, total and LDL cholesterol, and lower HDL cholesterol.
• Serum testosterone was not independently associated with ASCVD risk score or any individual cardiometabolic risk factor in the T2DM cohort.

Interpretation:

Remove unsupported claims about testosterone's correlation with cardiometabolic profiles.

Limitations:

• Cross-sectional design limits causal inference.
• Sample may not be representative of all Nigerian men with T2DM.

Conclusion:

Omit the suggestion for longitudinal studies as it is not directly supported by the source.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.